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Abstract 
Background: To develop pathways for advanced biofuel production, and to understand the impact of host metabo‑
lism and environmental conditions on heterologous pathway engineering for economic advanced biofuels produc‑
tion from biomass, we seek to redirect the carbon flow of the model ethanologen Zymomonas mobilis to produce 
desirable hydrocarbon intermediate 2,3‑butanediol (2,3‑BDO). 2,3‑BDO is a bulk chemical building block, and can be 
upgraded in high yields to gasoline, diesel, and jet fuel.
Results: 2,3‑BDO biosynthesis pathways from various bacterial species were examined, which include three genes 
encoding acetolactate synthase, acetolactate decarboxylase, and butanediol dehydrogenase. Bioinformatics analysis 
was carried out to pinpoint potential bottlenecks for high 2,3‑BDO production. Different combinations of 2,3‑BDO 
biosynthesis metabolic pathways using genes from different bacterial species have been constructed. Our results 
demonstrated that carbon flux can be deviated from ethanol production into 2,3‑BDO biosynthesis, and all three het‑
erologous genes are essential to efficiently redirect pyruvate from ethanol production for high 2,3‑BDO production in 
Z. mobilis. The down‑selection of best gene combinations up to now enabled Z. mobilis to reach the 2,3‑BDO produc‑
tion of more than 10 g/L from glucose and xylose, as well as mixed C6/C5 sugar streams derived from the deacetyla‑
tion and mechanical refining process.
Conclusions: This study confirms the value of integrating bioinformatics analysis and systems biology data during 
metabolic engineering endeavors, provides guidance for value‑added chemical production in Z. mobilis, and reveals 
the interactions between host metabolism, oxygen levels, and a heterologous 2,3‑BDO biosynthesis pathway. Taken 
together, this work provides guidance for future metabolic engineering efforts aimed at boosting 2,3‑BDO titer 
anaerobically.
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Background
With the thriving interest today in sustainable and secure 
domestic advanced hydrocarbon production, extensive 
research has been conducted on microorganisms that 
naturally produce high titers of intermediates for drop-in 
fuels upgrading. A number of microorganisms have been 
recently engineered to produce hydrocarbon or hydro-
carbon intermediates. However, there are only a few 
reports about the development of commercially viable 
strains for the production of advanced hydrocarbon or 
hydrocarbon intermediates. 2,3-butanediol (2,3-BDO) is 
an economically important platform bulk chemical that 
can be used in a variety of chemical feedstocks, liquid 
fuels, and biosynthetic building blocks, such as synthetic 
rubber, solvents, and food additives. For example, dehy-
dration can convert 2,3-BDO into methyl ethyl ketone, 
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which can be used as a liquid fuel additive; and 2,3-BDO 
can also be deoxydehydrated into 1,3-butadiene, which is 
a critical building block for synthetic rubber. 1,3-butadi-
ene can also be oligomerized in high yields to gasoline, 
diesel, and jet fuel [1–11]. 2,3-BDO can be produced effi-
ciently by fermentation with microorganisms, such as 
Klebsiella sp., Enterobacter sp., Serratia sp., Bacillus sp., 
and the yeast, Saccharomyces cerevisiae [1–5, 12–16]. 
The 2,3-BDO biosynthesis pathway in these microor-
ganisms utilizes three enzymes: acetolactate synthase 
(Als), acetolactate decarboxylase (AldC), and butan-
ediol dehydrogenase (Bdh), which convert, sequentially, 
pyruvate to α-acetolactate, acetoin, and then 2,3-butan-
ediol. High 2,3-BDO titer has been reported in native 
and engineered microorganisms, especially under fed-
batch fermentation conditions. This body of work has 
been reported and reviewed extensively with excellent 
summaries on 2,3-BDO production pathways, microor-
ganisms, pathway engineering strategies, operation con-
ditions, and downstream processing [1–4]. For example, 
microbial 2,3-BDO production using different bacterial 
species, substrates, and fermentation methods has been 
summarized by Ji et al. [3]. Work to demonstrate heter-
ologous 2,3-BDO production in the heterologous hosts E. 
coli [17–21] and cyanobacteria Synechococcus elongatus 
PCC 7942 (about 120 mg/L) [22, 23] as well as pure 2,3-
BDO stereoisomer production in E. coli [24–28] has also 
been reported. However, most of these strains are aero-
bic or classified as risk group 2 microorganisms, which 
are not suitable for commercial production due to EPA 
biosafety regulations. The cost of aeration at large scale 
is also widely considered a problem for economic pro-
duction. Moreover, most native microorganisms produce 
mixtures of three 2,3-BDO stereoisomers and, thus, met-
abolic engineering efforts are needed for production of 
pure stereoisomers [29–33].
Zymomonas mobilis is well known for both its high 
specific glucose uptake rate and rapid catabolism, and is 
engineered to metabolize all major biomass sugars [34–
38]. Improved Z. mobilis strains developed by DuPont 
and NREL have been used for commercial-scale cellu-
losic bioethanol production in DuPont’s cellulosic etha-
nol plant at Nevada, IA, which is currently licensed to 
China and Macedonia. A novel deacetylation and disc-
refining (DDR) process, also known as deacetylation 
and mechanical refining (DMR), followed by enzymatic 
hydrolysis, has been shown to result in low toxicity, high 
concentration mixed sugar syrups that are capable of 
producing high product titers in the biological upgrading 
of these sugars [39, 40]. Superior fermentation perfor-
mance using Z. mobilis for conversion of DDR or DMR 
sugar streams to ethanol has been demonstrated [41, 
42]. In addition, different approaches have been applied 
to develop the robust Z. mobilis 8b strains to enhance 
ethanol productivity in the presence of pretreatment 
inhibitors. These approaches include classical chemical 
mutagenesis and adaptation, transposon mutagenesis, as 
well as the forward genetics approach that resulted in the 
development of various robust strains [36, 43–49], such 
as the hydrolysate-tolerant mutant 8b-OEL22C (22C) 
[44]. To broaden the antibiotics availability for further 
metabolic engineering of commercially relevant Z. mobi-
lis strains, a new Z. mobilis strain, 9C, was generated 
from its parental strain, 8b [37], with both tetracycline 
and chloramphenicol antibiotics markers removed. We 
found that the performance of strain 9C in different sugar 
sources is same as that of 8b (Unpublished data).
Since the genome sequence and functional re-anno-
tation were reported [50, 51], a substantial library of 
systems biology data as well as several metabolic mod-
eling studies have been accumulated in recent years to 
better understand the inhibitor tolerance mechanisms 
of Z. mobilis [52–66]. These inhibitors include the end-
product ethanol and toxic compounds from pretreated 
biomass, such as acetate, furfural, and soluble phenolic 
compounds. This information laid a solid foundation 
for future systems biology studies and provided data 
for omics-guided metabolic engineering practices in Z. 
mobilis.
This work is focused on developing a novel process for 
anaerobic 2,3-BDO production from biomass derived 
mixed C5/C6 sugar streams. We aim to take advantage of 
Z. mobilis’ capabilities for rapid and efficient utilization 
of biomass-derived mixed sugar streams and redirect the 
carbon flux from ethanol to heterologous 2,3-BDO pro-
duction to avoid the problem of mixed stereoisomers in 
native strains for pure stereoisomer production. Once 
sufficiently understood, we will work to develop novel 
pathways for advanced biological upgrading of sugars to 
high carbon efficiency intermediates amenable to separa-
tions and catalytic upgrading to hydrocarbon fuels.
Results
Investigate 2,3‑BDO toxicity to Z. mobilis
First, we examined the feasibility of engineering Z. mobi-
lis for high 2,3-BDO production by investigating the tox-
icity of 2,3-BDO to Z. mobilis in RMG2 medium at 30 °C 
using the Bioscreen C high-throughput growth meas-
urement instrument. Our result showed that Z. mobilis 
tolerates higher concentration of 2,3-BDO than that of 
ethanol (Fig.  1). The growth rate decreased to 0.3  h−1 
when about 80  g/L 2,3-BDO was supplemented to the 
growth medium, whereas less than 45  g/L ethanol was 
needed to slow the growth of Z. mobilis to similar growth 
rate. When 80 g/L ethanol was added into the medium, 
the growth rate of Z. mobilis was only about one-third 
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of that observed for the same amount of 2,3-BDO 
added (Fig. 1). Even when the concentration of 2,3-BDO 
was increased to 100  g/L, the growth rate of Z. mobilis 
decreased to 0.25 h−1, but it was still more than half of 
the control without 2,3-BDO supplementation. The low 
toxicity of 2,3-BDO to Z. mobilis indicates that Z. mobilis 
has a strong potential for achieving high titers, rate, and 
yields for 2,3-BDO production.
Construct a minimized vector for pathway engineering
To maximize the pathway engineering potential allowing 
for large plasmid constructions such as the three-gene 
2,3-BDO pathway in this study, a minimized shuttle vec-
tor was constructed. The resultant plasmid, pEZ15Asp 
(pEZ), contains only the essential elements: origins of 
replication for both E. coli and Z. mobilis, an antibiotic 
marker of spectinomycin resistance gene addA, and mul-
tiple cloning sites and, therefore, significantly reduces its 
size when compared with the original plasmid (from 8 to 
3  kb). Multiple cloning sites include restriction enzyme 
sites of EcoRI, XbaI, SpeI and PstI for the Biobrick cloning 
strategy [67] enabling pathway engineering (see Table  1 
and S1A for plasmid information and sequence).
Identify and select 2,3‑BDO pathway genes 
for heterologous 2,3‑BDO pathway construction
Literature related to 2,3-BDO production was reviewed, 
which includes the analysis of native 2,3-BDO biosyn-
thesis pathways in addition to the expression of heter-
ologous enzymes for 2,3-BDO production [1, 2, 5, 10, 
12, 13, 15, 16, 19, 20, 23, 25, 27, 68, 69]. The 2,3-BDO 
pathways from Bacillus licheniformis and Enterobacter 
cloacae have been successfully expressed in E. coli [13, 
16, 30, 33, 70, 71], suggesting the feasibility of 2,3-BDO 
production in Z. mobilis. The gene combination result-
ing in high 2,3-BDO yields and experimental methods 
reported in these papers laid a solid foundation for our 
work. We then compiled a list of 2,3-BDO pathway genes 
and the promising source microorganisms. After elimi-
nating pathogenic organisms from our list, we chose two 
bacterial species, B. licheniformis and E. cloacae, for the 
source of our three-gene 2,3-BDO biosynthesis pathway 
reported here.
The sequences (nucleotide and protein) of three genes 
(als, aldC, and bdh) were extracted and BLASTed against 
the Z. mobilis genome including our recently updated 
native plasmid sequences. BLAST results indicate that 
Bdh only has homologs with low similarity in Z. mobi-
lis; therefore, heterologous bdh genes were included in 
our pathway engineering strategy. In addition, the reac-
tion that Bdh catalyzes is a reversible reaction, with some 
enzymes preferring NADPH as a cofactor. Bdh enzymes 
preferring the reduction reaction from acetoin to butan-
ediol using NADH were selected for minimizing redox 
imbalance and for achieving high 2,3-BDO yield.
Additional BLAST results for the other two enzymes 
required for 2,3-BDO production indicate that Z. mobi-
lis possesses three homologs to Als, of which ZMO1139/
ZMO1140 (IlvB/C) may form a complex contributing 
to amino acid biosynthesis. The homolog ZMO0687 
has a high similarity to the catabolic enzyme, Als. The 
high similarity between Als, IlvB (ZMO1139), and Pdc 
(ZMO1360) based on protein sequence alignment indi-
cates that there could potentially be competition among 
them for substrate (pyruvate) binding and utilization. 
Additionally, since Pdc in Z. mobilis is required for etha-
nol production, providing energy, and maintaining redox 
balance for robust cellular growth, strategies to shift the 
carbon flux toward 2,3-BDO production are required. 
This can be accomplished by inhibiting pdc gene expres-
sion and Pdc enzyme activity or by enhancing the perfor-
mance of the heterologous Als enzyme.
Gene expression patterns of the Als homologous gene 
in Z. mobilis were subsequently examined using public 
and in-house transcriptomic datasets of microarray and 
next-generation sequencing (NGS)-based RNA-Seq. The 
result indicated that the als gene homologs are abun-
dantly expressed under different conditions, and that 
ZMO0687 is also differentially expressed in cells grown 
from media containing different carbon sources (e.g., 
downregulated in xylose medium compared to glu-
cose). Furthermore, ZMO1141, which catalyzes the for-
mation of (R)-2,3-dihydroxy-3-methylbutanoate from 
α-acetolactate (hereafter referred to as acetolactate) 
for valine, isoleucine, and leucine biosynthesis, has an 
abundant transcript level of average log2-based micro-
array intensity result of 13.78 compared to 14.69 for pdc 
Fig. 1 The impact of meso‑2,3‑BDO and ethanol supplementation on 
growth of Z. mobilis in RMG medium at 30 °C using Bioscreen C. Rela‑
tive growth rate (%) is the percentage of growth rate with chemical 
supplementation compared to control without
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(Additional file 1: Table S1B); therefore, the acetolactate 
decarboxylase (AldC) to be engineered should have a 
strong affinity for the substrate acetolactate to compete 
with ZMO1141, thus ensuring carbon flux toward ace-
toin and 2,3-BDO.
Construct heterologous 2,3‑BDO pathway in Z. mobilis 
and optimize flask fermentation conditions
The gene expression cassettes containing the sequences 
of three codon-optimized 2,3-BDO pathway genes (als, 
aldC, and bdh) from B. licheniformis and E. cloacae 
as well as wild-type version from E. cloacae were then 
designed and synthesized (Table 2). As discussed above, 
Z. mobilis has three als gene homologs, but does not have 
the aldC and bdh genes needed for 2,3-BDO production. 
Additionally, since Z. mobilis Pdc is a very abundant and 
efficient enzyme with low Km (<0.31 mM) and high kcat 
(>100 1/s), a strong als gene may be needed to divert 
carbon flux from ethanol production to 2,3-BDO. We, 
therefore, constructed several pathways with either two 
genes (aldC and bdh) or three genes (als, aldC, and bdh). 
These genes were assembled using the Biobrick-based 
Table 1 The source and  components of  the 2,3-BDO pathway constructed and  the corresponding 2,3-BDO titer (g/L) 
after 24-h post-inoculation in Z. mobilis 8b
Culture condition: 40 mL RMG8 in 125-mL flask, 33 °C, 120 rpm
EC E. cloacea; BL B. lincheniformis. SpR spectinomycin resistance; TcR tetracycline resistance; CmR chloramphenicol resistance; TcS tetracycline sensitive; CmR 
chloramphenicol sensitive
Strain or plasmid Characteristic(s) Source or reference
Plasmids
 pEZ15Asp (pEZ) Shuttle vector contains Z. mobilis origin and E. coli origin p15A; SpR; Biobrick‑compatible This work
 pEZ‑GS6 pEZ containing construct GS6: aldC and bdh genes from E. cloacae driven by its native promoter [PEc_
(ALDC‑BDH)]
This work
 pEZ‑GS2 pEZ containing construct GS2: codon‑optimized aldC and bdh genes from E. cloacae driven by Pgap pro‑
moter [GS2: Pgap_(ALDC‑BDH)
This work
 pEZ‑BC3 pEZ containing construct BC3: codon‑optimized aldC and bdh genes from B. licheniformis driven by Pgap 
and Peno promoter respectively [(Pgap_ALDC)‑(Peno_BDH)]
This work
 pEZ‑BC4 pEZ containing construct BC4: alS gene from E. cloacae driven by its native promoter (PEc_ALSecwt) and 
GS6 construct [(PEc_ALSecwt)‑GS6]
This work
 pEZ‑BC5 pEZ containing construct BC5: codon‑optimized alS gene from E. cloacae driven by Peno (Peno_ALSecopt) 
and GS2 construct [(Peno_ALSecopt)‑GS2]
This work
 pEZ‑BC9 pEZ containing construct BC9: codon‑optimized alS gene from B. licheniformis driven by inducible promoter 
Ptet (Ptet_BlAls) and GS2 construct [(Ptet‑BlAls)‑GS2]
This work
 pEZ‑BC10 pEZ containing construct BC10: codon‑optimized alS gene from B. subtilis driven by inducible promoter Ptet 
(Ptet‑BsAls1) and GS2 construct [(Ptet‑BsAls1)‑GS2]
This work
 pEZ‑BC11 pEZ containing construct BC11: 2nd version of codon‑optimized alS gene from B. subtilis driven by inducible 
promoter Ptet (Ptet‑BsAlss) and GS2 construct [(Ptet‑BsAls2)‑GS2]
This work
Bacterial strains
 E. coli C2925 ara‑14 leuB6 fhuA31 lacY1 tsx78 glnV44 galK2 galT22 mcrA dcm‑6 hisG4 rfbD1 R(zgb210::Tn10) TcSendA1 rspL136 
(StrR) dam13::Tn9 (CmR) xylA‑5 mtl‑1 thi‑1 mcrB1 hsdR2
NEB
 8b Engineered Z. mobilis subsp. ZM4 strain for xylose utilization, TcRCmR [37]
 9C 8b derivative with tetracycline and chloramphenicol antibiotics markers cured, TcSCmS Lab stock
 22C 8b derivate with enhanced corn stover hydrolysate tolerance, TcRCmR [44]
 8b‑pEZ Z. mobilis 8b containing control plasmid pEZ This work
 8b‑GS2 Z. mobilis 8b containing plasmid pEZ‑GS2 This work
 8b‑GS6 Z. mobilis 8b containing plasmid pEZ‑GS6 This work
 8b‑BC3 Z. mobilis 8b containing plasmid pEZ‑BC3 This work
 8b‑BC4 Z. mobilis 8b containing plasmid pEZ‑BC4 This work
 8b‑BC5 Z. mobilis 8b containing plasmid pEZ‑BC5 This work
 22C‑pEZ Z. mobilis 22C containing control plasmid pEZ This work
 22C‑BC5 Z. mobilis 22C containing plasmid pEZ‑BC5 This work
 9C‑BC5 Z. mobilis 9C containing plasmid pEZ‑BC5 This work
 9C‑BC9 Z. mobilis 9C containing plasmid pEZ‑BC9 This work
 9C‑BC10 Z. mobilis 9C containing plasmid pEZ‑BC10 This work
 9C‑BC11 Z. mobilis 9C containing plasmid pEZ‑BC11 This work
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metabolic pathway engineering strategy and cloned into 
the minimized shuttle vector pEZ (Table  1). The results 
indicated that the three-gene pathways produced more 
2,3-BDO than did the two-gene pathways (Table  2; 
Fig. 2). 
Three constructs (vector control pEZ, two-gene path-
way plasmid pEZ-GS2, and three-gene pathway plasmid 
pEZ-BC5) were further compared in two strain back-
grounds of 8b or 22C (Table  1). The introduction of 
heterologous als gene significantly increased 2,3-BDO 
production by shifting carbon flow away from ethanol 
production (Fig. 2).
Clearly 2,3-BDO production could be significantly 
enhanced if the native ethanol production pathway was 
impeded by knocking out key ethanol production genes 
of pyruvate decarboxylase (pdc) and alcohol dehydroge-
nase (adh), which has been demonstrated in S. cerevi-
siae that 2,3-BDO production increased in Pdc-deficient 
mutants [5, 7–10]. We have attempted to knock out or 
knock down the pdc gene to divert carbon to 2,3-BDO 
production without success, a result consistent with 
previous reports that pdc is essential for native Z. mobi-
lis and cannot be completely knocked out. Furthermore, 
our efforts testing pdc knockout in 2,3-BDO production 
strains, such as 9C-BC5 and 9C-BC11, were also not suc-
cessful. We will continue to work on blocking the route 
from pyruvate to ethanol to maximize the potential 2,3-
BDO titer with balanced redox using similar strategies as 
reported in yeast [5, 6, 72–74].
To optimize the 2,3-BDO production, different flask 
fermentation conditions were first investigated using the 
three-gene pathway construct in the 22C background 
(22C-BC5) and using the empty vector pEZ as a negative 
control (Table 1; Fig. 3a). Results indicate that 2,3-BDO 
can be produced using mixed sugar conditions (glucose, 
or glucose and xylose), as well as from DMR-pretreated 
biomass (Fig.  3b). Growth conditions that varied the 
shaking speed and medium volume affecting oxygen 
dispersion impacted acetoin and 2,3-BDO production 
(Fig.  3b). For example, acetoin titers rose above 10  g/L 
when the shaking speed was increased to 200 rpm with 
40 mL medium in the 125-mL baffled flask (Fig. 3b).
Optimize heterologous 2,3‑BDO pathway to increase 
2,3‑BDO titer
Initial 2,3-BDO engineering efforts in introducing het-
erologous aldC and bdh genes into Z. mobilis resulted 
in the 2,3-BDO production of about 3.7  g/L, which 
confirms that both aldC and bdh genes are required 
for 2,3-BDO production in Z. mobilis. Furthermore, 
the addition of a heterologous als gene from E. cloa-
cae increased 2,3-BDO titers to about 5.0 g/L (Table 2), 
which again upheld the assumption that an additional 
als gene may be needed to redirect carbon flux from 
ethanol production into 2,3-BDO to compete with the 
abundant and highly active Z. mobilis Pdc enzyme. 
Our data thus suggested that the bottleneck reactions 
to increase 2,3-BDO production could be acetolactate 
generation from pyruvate and 2,3-BDO production 
from acetoin. We hypothesize that stronger als and bdh 
genes, or genes encoding more active enzymes, will 
boost BDO production.
Table 2 The source and  components of  the 2,3-BDO pathway constructed and  the corresponding 2,3-BDO titer (g/L) 
after 24-h post-inoculation in Z. mobilis 8b
Culture condition: 40 mL RMG8 in 125-mL flask, 33 °C, 120 rpm
EC E. cloacea; BL B. licheniformis
Strain Plasmid Promoter Species Enzymes Codon optimization BDO (g/L)
8b‑GS6 pEZ‑GS6 Wild‑type E. cloacea AldC, Bdh No 1.42
8b‑GS2 pEZ‑GS2 Pgap E. cloacea AldC, Bdh Yes 3.69
8b‑BC3 pEZ‑BC3 Pgap, Peno B. lincheniformis AldC, Bdh Yes 2.88
8b‑BC4 pEZ‑BC4 Wild‑type E. cloacea Als, AldC, Bdh No 1.9
8b‑BC5 pEZ‑BC5 Peno, Pgap E. cloacea Als, AldC, Bdh Yes 5.0
Fig. 2 Biomass (OD600 nm), acetoin, 2,3‑BDO, and ethanol titers after 
24‑h post‑inoculation in either a Z. mobilis 8b and 22C background 
host with control plasmid pEZ15Asp (pEZ), or two‑gene construct 
pEZ‑GS2, or the three‑gene construct pEZ‑BC5 at 33 °C, 120 rpm with 
40 mL RMG8 in 125‑mL flask
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To ascertain whether other heterologous als genes 
with higher specific enzymatic activities than E. cloacae 
one as reported in E. coli [16] could improve carbon flux 
from ethanol production into 2,3-BDO, als genes from B. 
licheniformis (BlAls) and B. subtilis (BsAls) were synthe-
sized and cloned. These included one codon-optimized 
BlAls gene and two versions of the BsAls genes (BsAls1 
and BsAls2) with different codon optimization outputs 
using Genscript’s codon optimization algorithm. The 
attempt to incorporate the als gene from B. lichenformis 
(BlAls) under control of the strong Peno promoter along 
with the expression of AldC and Bdh using the Z. mobilis 
Pgap strong promoter was unsuccessful. Besides the pos-
sibility of cell growth inhibition by the enzyme Als from 
B. licheniformis and B. subtilis, this could be due to the 
protein burden caused by strong heterologous pathway 
gene expression. About 50 % of the proteins in Z. mobi-
lis are involved in the glycolysis pathway [75]. This view 
is supported by a previous report that overexpression of 
plasmid-encoded protein led to the reduction of both gly-
colytic flux and growth rate due to protein burden [76]. 
Similarly, previous work also suggested that protein bur-
den could be the reason for the negative effect observed 
for the isopropyl β-d-thiogalactoside (IPTG) induction of 
2,3-BDO biosynthesis in a recombinant E. coli strain [26].
To test this speculation and avoid the potential meta-
bolic burden caused by strong heterologous gene expres-
sion, the strong Peno promoter was tested along with the 
Ptet inducible promoter for the construction of addi-
tional three-gene pathway constructs. These constructs 
also included a common aldC and bdh gene operon 
from E. cloacae driven by a strong promoter Pgap [Pgap-
(EcALDC-BDH)]. In total, six new 3-gene constructs 
with different versions of als genes from B. lincheniformis 
or B. subtilis were generated (BsAls1, BsAls2, and BlAls 
that were either driven by the strong Peno promoter or by 
the inducible Ptet promoter).
These six constructs were then transformed into Z. 
mobilis 9C (an 8b derivative that is lacking tetracycline 
and chloramphenicol resistance markers). Our result is 
consistent with our hypothesis that the transformation 
efficiencies were very high for plasmid constructs with 
the inducible promoter Ptet without tetracycline induc-
tion, but no positive transformants were obtained for 
constructs using the strong Peno promoter. 2,3-BDO 
production of three strains containing the three-gene 
construct with als driven by Ptet (Table 1) was measured, 
and the 2,3-BDO titer increased from 5–6 to 10–13 g/L 
(Table 3). In addition, it is apparent that the carbon was 
diverted from ethanol to 2,3-BDO production, consider-
ing the strong negative correlation between ethanol and 
BDO titers 3  days post-inoculation with an R-squared 
value of 0.98 (Table 3).
We further compared sugar consumption and 2,3-BDO 
production kinetics in glucose only or mixed sugars (glu-
cose and xylose) with the new strain producing the high-
est 2,3-BDO titers, 9C-BC11 (Table  1). We found that 
this strain is stable, and 2,3-BDO titers were more than 
13 g/L when grown in RMG8 or RMG8X6 media (Fig. 4). 
Notably, the addition of xylose delayed the sugar utili-
zation of glucose and xylose; as well as cellular growth 
(Fig. 4). Furthermore, xylose was not completely utilized 
even 5 days after inoculation (data not shown). However, 
the concentration of 2,3-BDO in the mixed sugar fermen-
tation remained level in stationary phase when compared 
to cultures grown in glucose only. In this case, levels of 
2,3-BDO decreased after growth, possibly because of the 
reverse activity of Bdh converting 2,3-BDO back to ace-
toin, since decreasing 2,3-BDO titers was accompanied 
by in acetoin concentration increase (Fig. 4a).
Fig. 3 Biomass (OD600 nm), acetoin, 2,3‑BDO, and ethanol titers after 
24‑h post‑inoculation under different fermentation conditions which 
varied shaking speed (120 or 200 rpm), volume (100 or 40 mL in 
125‑mL flask), and media (RMG8, RMG8X6, and DMR) for control strain 
22C(pEZ) (a) and three‑gene pathway construct Z. mobilis 22C‑BC5 
(b) at 33 °C
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Investigate fermentation conditions on 2,3‑BDO 
productions
To further understand the impact of oxygen concentra-
tion on 2,3-BDO production and fermentation byproduct 
profiles as indicated by flask fermentation optimization 
(Fig.  3), Biostat-Q Plus fermenters (Sartorius Stedim 
North America Inc., Bohemia, NY) with oxygen control 
capability were used for our highest 2,3-BDO produc-
ing strain, 9C-BC11. As a control, shake flask fermenta-
tion was also conducted. Glucose is usually consumed 
within 20  h by the parental strain 9C under anaerobic 
conditions. Interestingly, the glucose utilization of Z. 
mobilis 9C-BC11 under anaerobic conditions with N2 
purging was significantly reduced with only 3  g/L glu-
cose consumed and no discernible cellular growth after 
22 h post-inoculation. In contrast, more than half of the 
glucose had been used under shake flask conditions, and 
nearly all glucose was consumed upon reaching the high-
est OD600 nm value of 5.34 under microaerophilic condi-
tion of 1  % dissolved oxygen (DO) (Fig.  5a). However, 
glucose utilization and cellular growth were significantly 
decreased when 10  % DO was supplied. At 48-h post-
inoculation, there was still 34  g/L glucose remaining in 
the media, compared to other conditions tested where 
all glucose had been consumed (Fig. 5a), and the glucose 
level and OD600 nm values remained relatively steady out 
to 120 h post-inoculation (Additional file 1: Table S1C).
Under anaerobic conditions with nitrogen sparging, 
nearly all glucose was ultimately converted into ethanol, 
producing only 1.68  g/L 2,3-BDO. Increasing oxygen 
deliveries from 0 to 1 % DO, or 10 % DO, decreased etha-
nol production dramatically (Fig.  5b), and is consistent 
with a previous report that aerobic growth reduces etha-
nol production [63]. Although both 2,3-BDO and acetoin 
levels increased under aerobic growth, titers of 2,3-BDO 
and acetoin were significantly higher in the 1 % DO cul-
ture than in the 10 % DO culture (Fig. 5b, c).
Besides the major end-products ethanol, acetoin, 
and 2,3-BDO, the production profiles of minor byprod-
ucts of acetate, lactate, and glycerol were also affected 
by the oxygen levels in these cultures. More acetate was 
produced under aerobic conditions resulting in less 
ethanol production as reported in the literature [63]. 
Furthermore, acetate production was significantly higher 
in the more aerobic conditions (1 or 10 % DO supplemen-
tation) than in the microaerophilic conditions using flask 
fermentation or N2-supplemented anaerobic fermenta-
tion (Fig.  5d). Additionally, more lactate was produced 
under aerobic conditions than in anaerobic condition as 
well (Fig. 5d). We had previously shown that the expres-
sion levels of the lactate dehydrogenase gene ZMO1237 
were more abundant under aerobic conditions [63], and 
the expression of another d-lactate dehydrogenase gene, 
ZMO0256, was upregulated in the ethanol-treated cells 
during stationary phase [57]. The host strain, Z. mobilis 
9C, used in this study, is a derivative of Z. mobilis 8b in 
which the ZMO1237 gene was inactivated [37]. There-
fore, ZMO1237 may play the major role in lactate pro-
duction under aerobic conditions. However, another 
lactate dehydrogenase gene, ZMO0256, could also be 
activated under aerobic conditions for lactate produc-
tion, when ZMO1237 is deactivated, as shown in this 
study (Fig. 5d).
Intriguingly, despite the observation that more glycerol 
was produced under aerobic conditions (i.e., 1 or 10  % 
DO) than under anaerobic conditions with N2 purging, 
a higher amount of glycerol was produced in shake flask 
fermentations (see Fig. 5c). In Z. mobilis, only one NAD+ 
is regenerated from 2,3-BDO biosynthesis compared to 
two NAD+ from ethanol fermentation. The increase of 
glycerol production for in shake flasks may be explained 
by the utilization of the glycerol pathway to maintain 
redox balance (NAD+ feedback) while also provides ATP 
to sustain cellular growth (Fig. 6).
The highest 2,3-BDO yield (0.16  g/g glucose) was 
achieved under shake flask fermentations and the high-
est ethanol yield (0.44  g/g glucose) was obtained under 
anaerobic conditions using N2 purging (Additional file 1: 
Table S1C). As oxygen supplementation increased, ace-
toin yields also increased; however, these conditions also 
produced lower ethanol yields. In addition, the yields of 
all fermentation products (ethanol, lactate, glycerol, and 
acetate) were reduced with the increasing oxygen lev-
els. For example, ethanol yields decreased from 0.46 g/g 
glucose under anaerobic conditions to 0.15  g/g glucose 
in the 10  % DO culture (Additional file  1: Table S1C). 
Table 3 The source and components of the 2,3-BDO pathway constructed and the corresponding BDO titer 1 day post-
inoculation in Z. mobilis 9C
The promoter of als gene in these constructed is driven by inducible promoter Ptet. Culture condition: 40 mL RMG8 with 200 μg/mL spectinomycin in 125-mL flask, 
33 °C, 120 rpm. Four replicates each without tetracycline induction
Strain Plasmid Promoter als source Enzymes Acetoin (g/L) BDO (g/L) Ethanol (g/L)
9C‑BC9 pEZ‑BC9 Ptet B. licheniformis Als, AldC, Bdh 1.6 ± 0.4 10.8 ± 1.1 26.2 ± 0.5
9C‑BC10 pEZ‑BC10 Ptet B. subtilis Als, AldC, Bdh 1.1 ± 0.5 10.2 ± 2.0 27.4 ± 1.6
9C‑BC11 pEZ‑BC11 Ptet B. subtilis Als, AldC, Bdh 0.7 ± 0.1 13.3 ± 0.7 24.9 ± 0.5
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Conversely, the ratios of the heterologous products, ace-
toin and 2,3-BDO, to fermentation products increased 
from 0.04  g/g glucose under anaerobic conditions to 
1.65 g/g glucose when 10 % DO was used, which reflects 
the higher acetoin yields and also correlated to lower 
ethanol yields under aerobic conditions (Additional file 1: 
Fig. 4 Biomass (OD600 nm), and concentrations of acetoin, 2,3‑BDO, glycerol, ethanol as well as glucose and xylose for strain Z. mobilis 9C‑BC11 
grown in pure sugar of RMG8 (a) or mixed sugar of RMG8X6 (b). Culture condition: 40 mL RMG8 or RMG8X6 with 200 μg/mL spectinomycin in 125‑
mL flask, 33 °C, 120 rpm. Three replicates each without tetracycline induction
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Table S1C). We saw a similar result with shake flask fer-
mentations. Higher acetoin production was accompanied 
by lower ethanol titer under more aerobic conditions 
(40 mL media in a 125-mL flask at 120 rpm) (Fig. 3b).
Discussion
Zymomonas mobilis has attracted great attention due 
to its unique metabolic characteristics [49, 77–83]. 
Although it is missing two tricarboxylic acid cycle (TCA 
cycle) enzymes, malate dehydrogenase (Mdh) and 2-oxo-
glutarate dehydrogenase complex (Ogdh), as well as one 
key enzyme in the Embden–Meyerhof–Parnas (EMP) 
pathway (phosphofructokinase Pfk), Z. mobilis has out-
standing fermentation performance consuming sugars 
at very high ethanol productivity rates and producing 
high ethanol titers through the Entner–Doudoroff (ED) 
pathway to provide energy for efficient growth. Glyco-
lytic pathway enzymes are abundant in Z. mobilis which 
generate one ATP from each glucose molecule; com-
pared to 2 ATPs generated from the EMP pathway and 
38 ATPs from the TCA cycle. Zymomonas mobilis also 
has a respiration chain using oxygen as the terminal 
electron receptor under aerobic conditions. At least two 
branched electron transport systems have been proposed 
comprising NADH dehydrogenase (Ndh), coenzyme 
Q10, cytochrome bd, and O2, which has been confirmed 
by several studies [78, 81–87]. However, unlike other 
microorganisms, respiration in Z. mobilis is uncoupled 
to energetics and cellular growth with a function that has 
been suggested to maintain a low NADH/NAD+ ratio for 
efficient glycolysis and cellular growth [87]. Disturbance 
of the cellular NADH/NAD+ ratio due to external or 
internal inhibitors could lead to slow growth [48, 87]. A 
mutation of respiration chain genes, such as ndh muta-
tion, or the supplementation of respiration chain inhibi-
tors could result in better growth and higher ethanol 
titer under aerobic conditions [78, 81, 82, 84, 87] possibly 
due to more NADH becoming available for ethanol fer-
mentation. However, excessive NADH would result in a 
high NADH/NAD+ ratio which would lead to inhibition 
of cellular growth [87]. Therefore, a well-balanced, low 
NADH/NAD+ ratio is key for efficient glycolysis and cel-
lular growth in Z. mobilis.
Based on end-product data analysis for ethanol, ace-
toin, 2,3-BDO, lactate, acetate, and glycerol produc-
tion, as well as cellular growth and glucose consumption 
profiles described above (Fig.  5), we propose the model 
below to explain the impact of host carbon and energetic 
Fig. 5 BioStat‑Q plus fermentation profiles of glucose utilization and biomass (OD600 nm, a), 2,3‑BDO and ethanol (b), acetoin and glycerol (c), 
acetate and lactate (d) of three‑gene 2,3‑BDO pathway construct Z. mobilis 9C‑BC11 under different aeration conditions of N2 (0 % DO), 1, or 10 % 
DO (dissolved oxygen concentration) as well as shake flasks in RMG10 at pH 5.8 and 30 °C conditions 48‑h post‑inoculation
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metabolism as well as oxygen levels on heterologous 
2,3-BDO metabolic pathway engineering in Z. mobilis 
(Fig. 6).
We hypothesize that during anaerobic conditions, 
there is insufficient NAD+ produced during ethanol fer-
mentation to ensure efficient glucose catabolism in the 
engineered 2,3-BDO pathway in strain 9C-BC11 since 
pyruvate is being diverted away from ethanol production 
to 2,3-BDO. One acetolactate intermediate is synthesized 
from two pyruvate molecules by Als and then converted 
to acetoin and BDO by AldC and Bdh, respectively, oxi-
dizing one NADH to generate one NAD+ as opposed to 
two NAD+ generated from ethanol fermentation. Moreo-
ver, the 2,3-BDO biosynthesis pathway may also compete 
for the substrate, acetolactate, with the branded-chain 
amino acids biosynthesis pathway for valine, alanine, and 
leucine. Taken together, the reduced NAD+ generated 
via the heterologous 2,3-BDO metabolic pathway and 
the competition for substrate with the amino acid bio-
synthesis pathway may increase the NADH/NAD+ ratio, 
which could then reduce the glycolysis efficiency and cel-
lular growth resulting in a long lag phase (Fig. 5a). This 
lag could last until sufficient NAD+ could be generated to 
re-establish the optimal NADH/NAD+ ratio for efficient 
ethanol production.
Under 1  % DO culture conditions, we achieved the 
fastest glucose utilization and highest growth rates and 
the highest yields of 2,3-BDO and acetoin compared to 
anaerobic and 10  % DO conditions, suggesting that a 
more optimal redox balance is achieved under this con-
dition. However, lower 2,3-BDO titers were realized 
compared to shake flask conditions. Clearly, the high-
est oxygen level tested (10  %) negatively impacted glu-
cose utilization, cellular growth, and end-product yields 
(Fig.  5a, b, c), which may be due to an NADH/NAD+ 
ratio imbalance and thus inadequate NADH availability 
Fig. 6 Impact of heterologous 2,3‑BDO metabolic pathway engineering and oxygen levels on native central carbon metabolism in Z. mobilis. 
This figure shows native central carbon metabolism in Z. mobilis which includes ED (Entner–Doudoroff ), PPP (pentose phosphate pathway), and 
fermentation pathways leading to the production of ethanol and other minor metabolites of glycerol, lactate, and acetate from carbon source 
of glucose and xylose. The heterologous 2,3‑BDO biosynthesis pathway was integrated into Z. mobilis metabolic pathway, which contains three 
enzymes of acetolactate synthase (Als), acetolactate decarboxylase (AldC), and butanediol dehydrogenase (Bdh) for 2,3‑BDO biosynthesis from 
pyruvate. Depending on the source of Bdh enzyme from different microorganisms, three 2,3‑BOD stereoisomers of R,R‑2,3‑BDO, S,S‑2,3‑BDO, and 
meso‑2,3‑BDO could be produced. Reactions involved in redox cofactor (NADH/NAD+) regeneration were shown as well as the respiration chain 
enzymes and electron transfer in Z. mobilis. The interactions among these pathways can help understand the impact of host carbon and energetic 
metabolism as well as oxygen levels on heterologous 2,3‑BDO metabolic pathway engineering in Z. mobilis
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for 2,3-BDO biosynthesis and ethanol fermentation. Lac-
tate dehydrogenase upregulated by oxygen may further 
exacerbate this situation by diverting needed NADH to 
lactate biosynthesis.
Under shake flask fermentation condition, more NAD+ 
may be generated from the acetoin to 2,3-BDO reaction, 
which could help maintain the redox balance. However, 
since the 2,3-BDO biosynthesis reaction is not as efficient 
as ethanol fermentation in Z. mobilis and NADH was 
not as efficiently recycled, we speculate that accumula-
tion of more NADH is being diverted towards glycerol 
biosynthesis to regenerate NAD+ while also providing 
ATP for glycolysis and cellular growth. Since shake flask 
conditions achieved higher 2,3-BDO and ethanol yields 
with lower acetoin production than either 1 or 10 % DO 
fermentation conditions (Fig. 5b), we will further explore 
oxygenation levels and its impact on 2,3-BDO produc-
tion and develop a strategy to balance redox to ensure 
maximum 2,3-BDO production under “anaerobic” or 
microaerophilic conditions.
The different physiological changes of a 2,3-BDO pro-
ducer, therefore, could be contributed to the complex 
interplay between oxygen availability, the respiratory 
chain, oxygen and NADH cofactor requirement for het-
erologous 2,3-BDO biosynthesis and native glycolysis 
and ethanol fermentation pathways of Z. mobilis. In the 
presence of oxygen, Z. mobilis is able to oxidize NADH 
to NAD+ by the NADH oxidase Ndh in the respiratory 
chain. High levels of acetoin formation under these con-
ditions suggested that NADH is oxidized to NAD+ by 
the NADH oxidase with high oxygen levels and will then 
not be available for the conversion of acetoin to 2,3-BDO 
by butanediol dehydrogenase (Bdh). Certainly, it is also 
possible that the activity of the Bdh is not optimal under 
these conditions and thus Bdh cannot compete with 
NADH oxidase. Further research will be needed to inves-
tigate the impact of oxygen, the fate of the NADH, and 
the Bdh enzymatic performance to optimize 2,3-BDO 
production and develop strategies for “anaerobic” pro-
duction of 2,3-BDO in Z. mobilis.
Conclusion
In summary, we have demonstrated the successful redi-
rection of carbon flux from ethanol production in Z. 
mobilis to production of other hydrocarbon intermedi-
ates, such as 2,3-BDO, from glucose and xylose or mixed 
sugars from pretreated biomass hydrolysate. Our results 
indicate that all three genes of the heterologous 2,3-BDO 
biosynthesis pathway are essential for high 2,3-BDO 
production in Z. mobilis, and the bottleneck reactions 
are both the acetolactate generation from pyruvate and 
the 2,3-BDO production from acetoin. Pathway engi-
neering to introduce Als with strong enzyme activity on 
pyruvate for acetolactate generation increased 2,3-BDO 
titer. In addition, our results reveal the impact of host cel-
lular metabolism and the effect of oxygen levels on het-
erologous 2,3-BDO metabolic pathway engineering for 
2,3-BDO production in Z. mobilis which can illuminate 
potential strategies for anaerobic 2,3-BDO production 
improvement. Furthermore, our study confirms the value 
of integrating bioinformatics analysis and systems biol-
ogy data during metabolic engineering endeavors.
Methods
Bacterial strain and growth conditions
Zymomonas mobilis 8b was revived from frozen glycerol 
stocks for about 6–8 h in 10 mL RMG2 (20 g/L glucose, 
10  g/L yeast extract, 2  g/L KH2PO4) at 33  °C. Other 8b 
derivatives used in this work are: 22C, a hydrolysate-tol-
erant mutant strain; 9C, an 8b derivative with both chlo-
ramphenicol and tetracycline resistance genes removed. 
The final spectinomycin concentration used for Z. mobi-
lis is 200 and 50 μg/mL for E. coli.
Growth curve measurement using Bioscreen C
Growth of Z. mobilis was monitored by Bioscreen C 
using the 420–580  nm filter (Growth Curves USA, NJ) 
as described previously without shaking [88, 89]. Three 
replicates were used for each condition. The seed cul-
tures used for Bioscreen C were first revived from frozen 
glycerol stocks overnight in RMG2, then diluted 100-fold 
into fresh RMG2 until it reached exponential phase. The 
absorbance at OD600  nm was adjusted to 3, then added 
10-μL to each well containing 290-μL medium, such that 
the final OD600  nm  =  0.1. Procedures for measurement, 
recording of final cell densities, and calculations used to 
correct for non-linear response at high cell densities are 
previously reported [88, 89].
Minimized shuttle vector construction and 2,3‑BDO 
pathway assembly
A new minimized shuttle vector, pEZ15Asp, was 
designed and synthesized that includes origins of replica-
tion from both E. coli and Z. mobilis, antibiotics marker 
for the spectinomycin resistance gene, and multiple clon-
ing sites for Biobrick-based pathway assembly [67].
Wild-type and codon-optimized versions of three 
2,3-BDO biosynthesis pathway genes were synthesized 
by Genscript (NJ, USA). The genes were then assem-
bled in different combinations using Biobrick-based 
approaches. Specifically, the minimized shuttle vector 
pEZ15Asp (pEZ) was digested with EcoRI-HF and PstI-
HF (Bio-Rad, CA), which was treated using the Rapid 
DNA Dephos and Ligation Kit (Roche, CA) for dephos-
phorylation and then quantified using Nanodrop and gel 
electrophoresis followed by gel purification. The insert(s) 
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were also treated with restriction enzymes of EcoRI/SpeI 
or XbaI/PstI and then quantified again using Nanodrop 
and gel electrophoresis followed by gel purification. The 
insert and vector were ligated using the fast-ligation kit 
(NEB, CA) with a molecular ratio of 3:1 for insert to vec-
tor. The ligation product (2-μL) was used for transforma-
tion into NEB C2925 competent cells. The transformants 
were confirmed by colony PCR using the primers of 
pBAD-GFP_F/R (5′TCACCAGCTCACCGTCTTTC3′ 
and 5′CCTGATGAATGCTCATCCGG3′) to confirm the 
insert size. The gene-specific primers were used to con-
firm that the targeted genes were cloned into the vector. 
Colonies showing the expected PCR bands were inocu-
lated into LB broth supplemented with 50  μg/mL spec-
tinomycin overnight and the plasmids were extracted 
and confirmed by PCR, restriction digestion, and Sanger 
sequencing.
Electroporation transformation and 2,3‑BDO strain 
selection
Zymomonas mobilis or Escherichia coli cells were trans-
formed with plasmids by electroporation (Bio-Rad Gene 
Pulser, 0.1-cm gap cuvettes, 1.6  kV, 200  ohms, 25  μF). 
Electrocompetent Z. mobilis cells were prepared by cen-
trifuging cells from cultures that had reached an OD600 nm 
of 0.4–0.6. Cell pellets were washed once in ice-cold ster-
ile water, re-centrifuged, and washed again in 10 % glyc-
erol. These pellets were resuspended in 10 % glycerol at 
a concentration approximately 1000-fold higher than the 
starting culture. Competent cells were stored at −80  °C 
as small aliquots for later use. Transformants of E. coli 
or Z. mobilis were selected on LB or RMG agar plates, 
respectively, containing appropriate antibiotics. Due to 
the presence of restriction/modification systems in Z. 
mobilis [90] that can decrease transformation efficiency, 
all plasmids were built in and isolated from a methyla-
tion-deficient E. coli strain, C2925 (NEB, MA), for effi-
cient transformation into Z. mobilis 8b or its derivatives.
For single colony isolation, transformants grown on the 
selective plates containing spectinomycin were further 
streaked on RMG plates with spectinomycin at a final 
concentration of 200  μg/mL (RMGSp). Following isola-
tion, these colonies were then used for colony PCR to 
confirm the introduction of plasmids with correct path-
way genes using the primers pBAD-GFP_F/R to check 
the insert size and gene-specific primers. Colonies with 
expected PCR bands pattern were selected and inocu-
lated into RMGSp for preservation and further flask 
evaluation.
Lignocellulosic biomass sugar hydrolysate
Biomass sugar hydrolysates were prepared using DMR 
corn stover. The details of DMR pretreatment process 
were described elsewhere [42]. In brief, corn stover (INL 
LOT#6, harvested in Hurley County, SD) was knife 
milled to pass through a 19 mm (3/4-in.) rejection screen 
followed by dilute alkaline (NaOH at 0.1  M) deacetyla-
tion at 80  °C in a 1900-L paddle mixer to remove most 
of the acetyl groups and some of the lignin. The deacet-
ylated corn stover was disc refined at a specific refining 
energy of approximately 100 kW/ODMT in a pilot scale 
Sprout 401 (36-in.) disc refiner provided by Andritz, 
Inc., Springfield, OH. A secondary milling was applied to 
the deacetylated and disc refined corn stover substrates 
at 100kWh/ODMT using a planetary type Szego mill to 
further improve digestibility. The DMR-pretreated corn 
stover was then hydrolyzed using cellulases from Novo-
zyme as reported previously [41]. The hydrolysis was 
conducted at 15  % total solids, pH 5.2, 50  °C and com-
pleted in 5 days.
Shake flasks and Biostat‑Q fermentations
Seed cultures of Z. mobilis strains harvested at exponen-
tial phase were inoculated into 125-mL shake flasks con-
taining 40-mL media of RMG8 (RM with 80 g/L glucose) 
or RMG8X6 (RM with 80 g/L glucose and 60 g/L xylose) 
to a starting OD600  nm of 0.1. The medium was supple-
mented with spectinomycin at a final concentration of 
200  μg/mL. The temperature was maintained at 30 or 
33 °C with a shaking speed of 120 rpm.
For BiosStat-Q Plus fermentations, strains were revived 
from frozen stock on RMG5 (50  g/L glucose) in 50  mL 
baffled flasks containing 10 mL of media, and incubated 
overnight at 30 °C in a shaking incubator at 180 rpm. The 
revived and grown culture was used to start the seed cul-
ture for fermentation. The seed cultures were then pre-
pared in 125  mL shake flasks containing 40  mL RMG8 
(80 g/L glucose) using revived cultures and inoculated at 
an initial OD600 nm of 0.1. Seed flasks were incubated at 
30  °C overnight in a shaking incubator at 180 rpm. Fer-
mentations to evaluate the strains for BDO production 
were carried out in BioStat-Q plus fermenters with a 300-
mL working volume of RMG with higher glucose concen-
tration of 100 g/L (RMG10) to investigate whether higher 
carbon source could increase 2,3-BDO titer. The media 
were supplemented with spectinomycin at the final con-
centration of 200 μg/mL. The fermenters were inoculated 
from an overnight grown seed culture with an initial 
OD600  nm value of 0.1. The fermenter operated at 30  °C, 
300 rpm, and controlled at pH 5.8 with 4 N KOH.
High‑performance liquid chromatography (HPLC)
The dry weight of cells at the end of fermentation was 
determined by centrifuging 10 mL of broth and washing 
the cells with double deionized H2O. The washed cells 
were placed in pre-weighed aluminum dishes and dried 
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overnight at an 85 °C incubator. The correlation between 
dry cell weight and OD600  nm value was then calculated 
and used to estimate the dry cell weight in other time 
points.
Samples from the shake flasks or fermenters were 
taken at various time points. The samples were diluted 
for OD600  nm measurement. In addition, samples were 
filtered through a 0.2-μm syringe filter into HPLC vials. 
Concentrations of glucose, xylose, 2,3-BDO, acetoin, 
xylitol, ethanol, HMF, furfural, lactic acid, glycerol, and 
acetic acid were determined from filtered sample super-
natants by Agilent 1100 series HPLC (Agilent, CA) uti-
lizing a BioRad Aminex HPX-87H organic acids column 
and Cation H+ guard cartridge (Bio-Rad, CA) operating 
at 65  °C. A refractive index detector was used for com-
pound detection. Dilute sulfuric acid (0.01  N) was used 
as the isocratic mobile phase at a flow rate of 0.6  mL/
min, following published procedures [41]. Sugar utiliza-
tion, 2,3-BDO, acetoin, and ethanol titers were calculated 
based on the HPLC and dry cell weight data.
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